Innoviva, Inc.INVANASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank64
5Y CAGR-5.2%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
-5.2%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 202568.46%
Q3 202528.71%
Q2 2025236.49%
Q1 2025-331.25%
Q4 20241549.48%
Q3 2024103.53%
Q2 2024-194.83%
Q1 2024-40.21%
Q4 2023-23.02%
Q3 20236200.00%
Q2 2023-96.08%
Q1 2023152.04%
Q4 2022-125.72%
Q3 202238000.00%
Q2 2022-95.65%
Q1 202253.33%
Q4 2021-85.58%
Q3 20212.97%
Q2 20218.60%
Q1 202175.47%
Q4 202089.29%
Q3 2020-63.16%
Q2 202016.92%
Q1 202044.44%
Q4 201915.38%
Q3 20195.41%
Q2 201912.12%
Q1 2019-87.36%
Q4 2018455.32%
Q3 2018-12.96%
Q2 201886.21%
Q1 2018-47.27%
Q4 2017150.00%
Q3 2017-33.33%
Q2 2017106.25%
Q1 2017-33.33%
Q4 201671.43%
Q3 20167.69%
Q2 2016225.00%
Q1 20160.00%